跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
黃 芝瑋
副研究員
,
醫學科技學院
https://orcid.org/0000-0002-2551-6199
電子郵件
gracehuang
tmu.edu
tw
h-index
554
引文
15
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2014
2024
每年研究成果
概覽
指紋
網路
專案
(6)
研究成果
(55)
資料集
(1)
類似的個人檔案
(8)
指紋
查看啟用 Chih-Wei Huang 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Proton Pump Inhibitor
58%
Case-Control Study
55%
Breast Cancer
54%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
54%
Statin (Protein)
47%
Clinical Research
44%
Benzodiazepine
43%
Cohort Study
38%
Traditional Chinese Medicine
38%
Angiotensin
38%
Observational Study
32%
Disease
32%
Comorbidity
30%
Cancer Registry
27%
Stomach Cancer
24%
Lung Cancer
22%
Angiotensin Receptor Antagonist
22%
Acetylsalicylic Acid
22%
Metformin
22%
Endometrium Cancer
20%
Uterine Cervix Cancer
20%
Dipeptidyl Carboxypeptidase Inhibitor
19%
Female Genital Tract Cancer
19%
Liver Cell Carcinoma
19%
Low Density Lipoprotein
19%
Major Adverse Cardiac Event
19%
Gout
19%
Thorax Pain
19%
Community Acquired Pneumonia
19%
Omega 6 Fatty Acid
19%
High Density Lipoprotein
19%
Lipoprotein
19%
Health Status
19%
Intubation
19%
Infection
19%
Chronic Kidney Failure
19%
Aldosterone
19%
Hemodialysis
19%
Parkinson's Disease
19%
Arteriovenous Fistula
19%
Epidermal Growth Factor Receptor
19%
Vaccination Policy
19%
Renin
19%
Prevalence
15%
Drug Interaction
15%
Ovary Cancer
12%
Random Effects Model
12%
Biological Marker
11%
Liver Cancer
11%
Medicine and Dentistry
Cancer Risk
76%
Malignant Neoplasm
72%
Odds Ratio
60%
Proton-Pump Inhibitor
58%
Case-Control Study
48%
Electronic Health Record
44%
Patient Care
41%
Computerized Physician Order Entry
40%
Randomized Controlled Trial
40%
Physician
38%
Empathy
38%
Breast Cancer
32%
Logistic Regression Analysis
28%
Clinical Research
26%
Health Care
25%
Medicine
24%
Stomach Cancer
22%
Drug Use
22%
Patient Satisfaction
22%
Drug Therapy
21%
Hepatocellular Carcinoma
19%
Female Genital Tract Cancer
19%
Patient Safety
19%
COVID-19
19%
Cohort Analysis
19%
Meta-Analysis
19%
Disease Association
19%
Arteriovenous Fistula
19%
Renin Angiotensin Aldosterone System
19%
Hemodialysis
19%
Critical Appraisal
19%
Maturation
19%
Benzodiazepine
19%
Community-Acquired Pneumonia
19%
Gene Expression Profiling
19%
Gout
19%
Blood Pressure
19%
Internal Medicine
19%
Dermatosis
19%
Checklist
19%
Occupation (Patient Social Context)
19%
Chronic Kidney Disease
19%
4 Iodo 2,5 Dimethoxyamphetamine
19%
Traditional Chinese Medicine
19%
Digital Health
19%
Prevalence
18%
Cervical Cancer
16%
Endometrial Cancer
16%
Cardiology
14%
Doctor Patient Relation
13%
Nursing and Health Professions
Meta Analysis
38%
Hemodialysis
38%
Patient Care
33%
Electronic Health Record
29%
Odds Ratio
26%
Confidence Interval
25%
Receiver Operating Characteristic
24%
Breast Cancer
23%
Artificial Intelligence
22%
Physician
19%
Non Melanoma Skin Cancer
19%
Cohort Analysis
19%
Public Health Informatics
19%
Statin (Protein)
19%
Liver Cell Carcinoma
19%
Health Care Delivery
19%
Empathy
19%
Healthcare System
19%
Hospital
19%
Pilot Study
19%
Case-Control Study
19%
Drug Use
19%
Gout
19%
Pressure Injury
19%
Malignant Neoplasm
19%
Loneliness
19%
Robotics
19%
Long Term Care
19%
Hospital Service
19%
Chronic Kidney Failure
19%
Image Subtraction
19%
Arteriovenous Fistula
19%
Health Literacy
19%
Bibliometrics
19%
Drug Therapy
16%
Area under the Curve
16%
Disease
16%
Sensitivity and Specificity
11%
Infection
11%
Health Care Personnel
11%
Doctor Patient Relation
11%
Laxative
10%
Statins therapy
9%
Comorbidity
9%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
6%
Health Status
6%
Resource Allocation
6%
Vaccination Policy
6%
Neutrophil Count
6%
Predictive Value
6%
